Out Ruud, Hoekstra Menno, Hildebrand Reeni B, Kruit Janine K, Meurs Illiana, Li Zhaosha, Kuipers Folkert, Van Berkel Theo J C, Van Eck Miranda
Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Einsteinweg 55, 2333CC Leiden, The Netherlands.
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2295-300. doi: 10.1161/01.ATV.0000237629.29842.4c. Epub 2006 Jul 20.
ABCG1 has recently been identified as a facilitator of cellular cholesterol and phospholipid efflux to high-density lipoprotein (HDL). Its expression in macrophages is induced during cholesterol uptake in macrophages and by liver X receptor (LXR). The role of macrophage ABCG1 in atherosclerotic lesion development is, however, still unknown.
To assess the role of macrophage ABCG1 in atherosclerosis, we generated low-density lipoprotein (LDL) receptor knockout (LDLr-/-) mice that are selectively deficient in macrophage ABCG1 by using bone marrow transfer (ABCG1-/- --> LDLr-/-). Peritoneal macrophages isolated from donor ABCG1-/- mice exhibited a 22% (P=0.0007) decrease in cholesterol efflux to HDL. To induce atherosclerosis, transplanted mice were fed a high-cholesterol diet containing 0.25% cholesterol and 15% fat for 6 and 12 weeks. Serum lipid levels and lipoprotein profiles did not differ significantly between ABCG1-/- --> LDLr-/- mice and controls. In lungs of ABCG1-/- --> LDLr-/- mice a striking accumulation of lipids was observed in macrophages localized to the subpleural region. After 6 weeks of high-cholesterol diet feeding the atherosclerotic lesion size was 49+/-12x10(3) microm2 for ABCG1+/+ --> LDLr-/- mice versus 65+/-15x103 microm2 for ABCG1-/- --> LDLr-/- mice and after 12 weeks of high-cholesterol diet feeding 124+/-17x10(3) microm2 for ABCG1+/+ --> LDLr-/- mice versus 168+/-17x10(3) microm2 for ABCG1-/- --> LDLr-/- mice. Atherosclerotic lesion size depended on both time and the macrophage ABCG1 genotype (P=0.038 by 2-way ANOVA, n > or = 8), indicating a moderately 33% to 36% increase in lesion formation in the absence of macrophage ABCG1.
Macrophage ABCG1 deficiency does lead to heavy lipid accumulation in macrophages of the lung, and also a moderately significant effect on atherosclerotic lesion development was observed.
ABCG1最近被确定为细胞胆固醇和磷脂向高密度脂蛋白(HDL)流出的促进因子。其在巨噬细胞中的表达在巨噬细胞摄取胆固醇期间以及由肝脏X受体(LXR)诱导。然而,巨噬细胞ABCG1在动脉粥样硬化病变发展中的作用仍不清楚。
为了评估巨噬细胞ABCG1在动脉粥样硬化中的作用,我们通过骨髓移植(ABCG1-/-→LDLr-/-)生成了选择性缺乏巨噬细胞ABCG1的低密度脂蛋白(LDL)受体敲除(LDLr-/-)小鼠。从供体ABCG1-/-小鼠分离的腹膜巨噬细胞向HDL的胆固醇流出减少了22%(P = 0.0007)。为了诱导动脉粥样硬化,给移植的小鼠喂食含有0.25%胆固醇和15%脂肪的高胆固醇饮食6周和12周。ABCG1-/-→LDLr-/-小鼠和对照组之间的血清脂质水平和脂蛋白谱没有显著差异。在ABCG1-/-→LDLr-/-小鼠的肺中,在胸膜下区域的巨噬细胞中观察到脂质的显著积累。高胆固醇饮食喂养6周后,ABCG1+/+→LDLr-/-小鼠的动脉粥样硬化病变大小为49±12×10(3)平方微米,而ABCG1-/-→LDLr-/-小鼠为65±15×103平方微米;高胆固醇饮食喂养12周后,ABCG1+/+→LDLr-/-小鼠为124±17×10(3)平方微米,而ABCG1-/-→LDLr-/-小鼠为168±17×10(3)平方微米。动脉粥样硬化病变大小取决于时间和巨噬细胞ABCG1基因型(双向方差分析P = 0.038,n≥8),表明在没有巨噬细胞ABCG1的情况下病变形成适度增加33%至36%。
巨噬细胞ABCG1缺乏确实导致肺巨噬细胞中大量脂质积累,并且还观察到对动脉粥样硬化病变发展有适度显著的影响。